Skip to content

Study · Case report or series · n = 1 · 1991

1 result

Pulmonary edema possibly developing secondary to the intravenous administration of oxytocin.

Shahin J, Guharoy SR

Veterinary and human toxicology1 Dec 1991Cited by 8 (Europe PMC)

PMID1808838 (opens in a new tab)PepBankPUB-01808838
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In one reported patient, acute pulmonary edema possibly developed secondary to intravenous oxytocin.

    In plain wordsIn one patient, lung fluid buildup may have been caused by oxytocin given into a vein.

    Peptide
    Oxytocin
    Outcome
    Not applicableAcute pulmonary edema
    Study

    n = 1

    Outcome group
    Adverse events · Respiratory
    Studied dose
    Dose not stated · intravenousAs given in this study (human).

    Source sentences

    Summary
    We describe a case of acute pulmonary edema possibly developing secondary to the administration of iv oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:51 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.